Physician profile
Brian Darrith
NPI 1881186807
$5,992.73
in general payments reported to CMS, 2019-2025
8 companies · $1,176 in 2025
The $1,176 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $668 · 2023: $1,532 · 2024: $2,617 · 2025: $1,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,354 · Food and Beverage: $1,924 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,353.94 |
| Food and Beverage | $1,924.04 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,584.91 | 2023-2025 | Oxford, Persona, Custom Joint |
| Smith+Nephew, INC. | $1,420.05 | 2023 | Trigen, Evos |
| Stryker Corporation | $722.58 | 2022-2024 | Triathlon, Restoration, Mako |
| Depuy Synthes Sales INC. | $100.00 | 2024 | |
| Exactech, INC. | $63.94 | 2022 | |
| Onkos Surgical, INC. | $57.03 | 2025 | Eleos Limb Salvage System |
| Bioventus LLC | $30.50 | 2025 | Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $13.72 | 2024 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Darrith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.